Genenta Science S.p.A. (GNTA) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
GNTA Profit Margin, ROE & Profitability Analysis
GNTA vs Healthcare Sector: How Genenta Science S.p.A. Compares
How Genenta Science S.p.A. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Genenta Science S.p.A. Stock Overvalued? GNTA Valuation Analysis 2026
Based on fundamental analysis, Genenta Science S.p.A. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Genenta Science S.p.A. Balance Sheet: GNTA Debt, Cash & Liquidity
GNTA Revenue Growth, EPS Growth & YoY Performance
GNTA SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Genenta Science S.p.A. (CIK: 0001838716)
📋 Recent SEC Filings
❓ Frequently Asked Questions about GNTA
What is the AI rating for GNTA?
Genenta Science S.p.A. (GNTA) has an AI grade of N/A with 0% confidence, based on fundamental analysis of SEC EDGAR filings.
What are GNTA's key strengths?
Claude: Analysis in progress.
What are the risks of investing in GNTA?
Claude: Analysis in progress.
What is GNTA's revenue and growth?
Genenta Science S.p.A. reported revenue of N/A.
Does GNTA pay dividends?
Genenta Science S.p.A. does not currently pay dividends.
Where can I find GNTA SEC filings?
Official SEC filings for Genenta Science S.p.A. (CIK: 0001838716) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is GNTA's EPS?
Genenta Science S.p.A. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is GNTA's fundamental grade?
Based on our AI fundamental analysis in May 2026, Genenta Science S.p.A. has a N/A grade with 0% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is GNTA stock overvalued or undervalued?
Valuation metrics for GNTA: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is GNTA's AI grade for 2026?
Our dual AI analysis gives Genenta Science S.p.A. a combined N/A grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is GNTA's free cash flow?
Genenta Science S.p.A.'s operating cash flow is N/A, with capital expenditures of N/A.
How does GNTA compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).